Experimental drug can reduce symptoms of inflammatory bowel

A new study of mice and lab-grown human colon "organoids" indicates that an experimental drug developed by Johns Hopkins Medicine researchers can substantially reduce symptoms of inflammatory bowel disease (IBD) in pre-clinical models.

Related Keywords

Johns Hopkins University , Maryland , United States , National Institutes Of Health , Baltimore , Americans , Barbara Slusher , Lily Ramsey , Shinji Sakamoto , Vijayabhaskar Veeravalli , Lukas Tenora , Christine Mcdonald , Pavel Majer , Arindom Pal , Andras Ponti , Xiaolei Zhu , Ajit Thomas , Manisha Pradhan , Lauren Norris , Diane Peters , Johns Hopkins University School Of Medicine , Slusher Lab , Us Centers For Disease , Crohn Colitis Foundation , Johns Hopkins Medicine , Disease Control , Science Translational , Johns Hopkins Drug Discovery , Johns Hopkins University School , Rana Rais , Johns Hopkins Drug , Colitis Foundation , National Institutes , Blackbird Laboratories , Blackbird Labs , Abdominal Pain , Bleeding , Hronic , Crohn 39s Disease , Drug Discovery , Efficacy , Nzyme , Immune System , Inflammation , Inflammatory Bowel Disease , Medicine , Eurology , Rganoids , Rain , Mh , Protein , Ulcerative Colitis ,